Pfizer Vaccine on Track for Regulatory Review in October

(Bloomberg) -- Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional d...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.